Glenmark Pharmaceuticals gains on initiating clinical investigation for GBR 310

25 Apr 2017 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 890.50, up by 7.40 points or 0.84% from its previous closing of Rs. 883.10 on the BSE.

The scrip opened at Rs. 890.00 and has touched a high and low of Rs. 893.00 and Rs. 881.50 respectively. So far 11,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 993.00 on 01-Nov-2016 and a 52 week low of Rs. 729.30 on 24-Jun-2016.

Last one week high and low of the scrip stood at Rs. 918.95 and Rs. 876.10 respectively. The current market cap of the company is Rs. 25,127.00 crore.

The promoters holding in the company stood at 46.51%, while Institutions and Non-Institutions held 40.80% and 12.69% respectively.

Glenmark Pharmaceuticals has initiated Clinical Investigation for GBR 310, its proposed Biosimilar Candidate for XOLAIR. The US Food and Drug Administration (USFDA) cleared the company’s Investigational New Drug (IND) application to initiate a first-in-human study of GBR 310, a proposed biosimilar, which will assess its pharmacokinetics in comparison to XOLAIR (omalizumab) in healthy adult volunteers between 18 - 65 years of age.

GBR 310 is a recombinant DNA-derived humanized immunoglobulin G1 kappa monoclonal antibody. Its current proposed indication is for the treatment of allergic asthma and chronic idiopathic urticaria. The reference product for GBR 310 is omalizumab, available under the brand name XOLAIR.

According to IMS sales data for the 12-month period ending February 2017, annual sales of XOLAIR 150 mg injection was approximately $1.7 billion in the US.


Glenmark Pharma Share Price

1965.35 -25.30 (-1.27%)
20-Jan-2026 12:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.80
Dr. Reddys Lab 1184.75
Cipla 1378.90
Zydus Lifesciences 877.00
Lupin 2167.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×